Please login to the form below

Not currently logged in
Email:
Password:

Pomalyst

This page shows the latest Pomalyst news and features for those working in and with pharma, biotech and healthcare.

GSK preps filings for BCMA-targeting multiple myeloma drug

GSK preps filings for BCMA-targeting multiple myeloma drug

It is already recruiting patients into a phase 1/2 trial (DREAMM-4) looking at the combination of the BCMA drug with Pomalyst, as well as six other studies looking at

Latest news

More from news
Approximately 3 fully matching, plus 21 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Attigo (part of the Mednet Group)

We are socially intuitive. Attigo deliver inspiring creative healthcare communications, whilst leading the way as partner of choice for socially-conscious...

Latest intelligence

Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...
What is changing in mental health and dementia care?
Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...

Infographics